EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy

Jiang Long, Xiaoya Liang, Zuojin Ao, Xiao Tang, Chuang Li, Kexin Yan, Xin Yu, Ying Wan, Yao Li, Chunhong Li, Meiling Zhou

Acta Biomaterialia · 2024-10 · 188 · 27-47

DOI: 10.1016/j.actbio.2024.09.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2024-10. Verfasst von Jiang Long und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xuyong County People's Hospital, Luzhou, Sichuan 646000, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) manifests as inflammation in the colon, rectum, and ileum, presenting a global health concern with increasing prevalence. Therefore, effective anti-inflammatory therapy stands as a promising strategy for the prevention and management of IBD. However, conventional nano drug delivery systems (NDDSs) for IBD face many challenges in targeting the intestine, such as physiological and pathological barriers, genetic variants, disease severity, and nutritional status, which often result in nonspecific tissue distribution and uncontrolled drug release. To address these limitations, stimulus-responsive NDDSs have received considerable attention in recent years due to their advantages in providing controlled release and enhanced targeting. This review provides an overview of the pathophysiological mechanisms underlying IBD and summarizes recent advancements in microenvironmental stimulus-responsive nanocarriers for IBD therapy. These carriers utilize physicochemical stimuli such as pH, reactive oxygen species, enzymes, and redox substances to deliver drugs for IBD treatment. Additionally, pivotal challenges in the future development and clinical translation of stimulus-responsive NDDSs are emphasized. By offering insights into the development and optimization of stimulus-responsive drug delivery nanoplatforms, this review aims to facilitate their application in treating IBD. STATEMENT OF SIGNIFICANCE: This review highlights recent advancements in stimulus-responsive nano drug delivery systems (NDDSs) for the treatment of inflammatory bowel disease (IBD). These innovative nanoplatforms respond to specific environmental triggers, such as pH reactive oxygen species, enzymes, and redox substances, to release drugs directly at the inflammation site. By summarizing the latest research, our work underscores the potential of these technologies to improve drug targeting and efficacy, offering new directions for IBD therapy. This review is significant as it provides a comprehensive overview for researchers and clinicians, facilitating the development of more effective treatments for IBD and other chronic inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesHumansAnimalsDrug Delivery SystemsNanoparticlesAnti-Inflammatory AgentsDrug CarriersNanoparticle Drug Delivery System

Stichwörter der Autor:innen

Drug delivery carrierEnzymeInflammatory bowel disease therapyReactive oxygen speciesStimuli-responsive nanoplatformspH

Substanzen

Anti-Inflammatory AgentsDrug CarriersNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Cardiology, Xuyong County People's Hospital, Luzhou, Sichuan 646000, China.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.
  • Analysis and Testing Center, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.
  • College of Integrated Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
  • Chinese Pharmacy Laboratory, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan 646000, China.
  • School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646000, China.

Förderung

  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Long, J., Liang, X., Ao, Z., Tang, X., Li, C., Yan, K., Yu, X., Wan, Y., Li, Y., Li, C., & Zhou, M. (2024). Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy. Acta Biomaterialia, 188, 27-47. https://doi.org/10.1016/j.actbio.2024.09.007

Vancouver

Long J, Liang X, Ao Z, Tang X, Li C, Yan K, et al. Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy. Acta Biomaterialia. 2024;188:27-47. doi:10.1016/j.actbio.2024.09.007

BibTeX
@article{Long2024,
  author = {Long, Jiang and Liang, Xiaoya and Ao, Zuojin and Tang, Xiao and Li, Chuang and Yan, Kexin and Yu, Xin and Wan, Ying and Li, Yao and Li, Chunhong and Zhou, Meiling},
  title = {Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy},
  journal = {Acta Biomaterialia},
  year = {2024},
  volume = {188},
  pages = {27--47},
  doi = {10.1016/j.actbio.2024.09.007}
}
Kostenlos starten →